TY - JOUR
T1 - Results in comparison between 30 gauge ultrathin wall and 27 gauge needle in sutureless intraocular lens flanged technique in diabetic patients
T2 - 24-month follow-up study
AU - Iglicki, Matias
AU - Zur, Dinah
AU - Negri, Hermino Pablo
AU - Esteves, Joaquin
AU - Arias, Romina
AU - Holsman, Emanuel
AU - Loewenstein, Anat
AU - Busch, Catharina
N1 - Publisher Copyright:
© 2020, Springer-Verlag Italia S.r.l., part of Springer Nature.
PY - 2020/10/1
Y1 - 2020/10/1
N2 - Aims: Intraoperative complications in cataract surgery are more common in diabetic patients. Solving aphakia in these circumstances remains a challenge, as the scleral structure has been shown to be different in diabetes. This study aims to analyze the role of a secondary sutureless scleral intraocular lens (IOL) flanged fixation in diabetic patients without capsular support and to compare the anatomical and functional outcomes using a 30 gauge (G) ultrathin wall needle vs. a 27G needle. Methods: Retrospective, observational cohort study. 105 eyes (105 patients) who underwent PPV with secondary IOL fixation using a sutureless 27G (n = 51) or a 30G ultrathin wall (UTW) needle technique (n = 54) and had a 24 months postoperative follow up. Consecutive patients’ records were reviewed for lens stability and centration parameters, intra- and postoperative complications at 7 days, 1, 3, 6, 12, and 24 months after surgery. Correlations between outcome measures and needle size (27G vs. 30G UTW) were analyzed. Results: IOL displacement occurred in 30 patients (41.2%) in the 27G group and did not occur in the 30G UTW needle group (p < 0.001). Mean time until IOL displacement was 10.5 ± 7.0 months (range: 7 days–24 months). IOL centricity was significantly better in the 30G ultrathin wall needle group compared to 27 G (p = 0.001). Additional surgical interventions were necessary only in the 27G group (n = 14). Conclusions: Sutureless IOL flanged technique using a 30G UTW needle is more predictable and has less complications in aphakic diabetic patients, compared to a 27G needle technique.
AB - Aims: Intraoperative complications in cataract surgery are more common in diabetic patients. Solving aphakia in these circumstances remains a challenge, as the scleral structure has been shown to be different in diabetes. This study aims to analyze the role of a secondary sutureless scleral intraocular lens (IOL) flanged fixation in diabetic patients without capsular support and to compare the anatomical and functional outcomes using a 30 gauge (G) ultrathin wall needle vs. a 27G needle. Methods: Retrospective, observational cohort study. 105 eyes (105 patients) who underwent PPV with secondary IOL fixation using a sutureless 27G (n = 51) or a 30G ultrathin wall (UTW) needle technique (n = 54) and had a 24 months postoperative follow up. Consecutive patients’ records were reviewed for lens stability and centration parameters, intra- and postoperative complications at 7 days, 1, 3, 6, 12, and 24 months after surgery. Correlations between outcome measures and needle size (27G vs. 30G UTW) were analyzed. Results: IOL displacement occurred in 30 patients (41.2%) in the 27G group and did not occur in the 30G UTW needle group (p < 0.001). Mean time until IOL displacement was 10.5 ± 7.0 months (range: 7 days–24 months). IOL centricity was significantly better in the 30G ultrathin wall needle group compared to 27 G (p = 0.001). Additional surgical interventions were necessary only in the 27G group (n = 14). Conclusions: Sutureless IOL flanged technique using a 30G UTW needle is more predictable and has less complications in aphakic diabetic patients, compared to a 27G needle technique.
KW - 27 Gauge
KW - 30 Gauge
KW - Aphakia
KW - Diabetes mellitus
KW - Flanged technique
KW - Sutureless intraocular lens fixation
KW - Ultrasound biomicroscopy
UR - http://www.scopus.com/inward/record.url?scp=85083511905&partnerID=8YFLogxK
U2 - 10.1007/s00592-020-01530-8
DO - 10.1007/s00592-020-01530-8
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 32300875
AN - SCOPUS:85083511905
SN - 0940-5429
VL - 57
SP - 1151
EP - 1157
JO - Acta Diabetologica
JF - Acta Diabetologica
IS - 10
ER -